AstraZeneca-Merck’s Lynparza wins EU approval for pancreatic cancer Reuters Jul 8, 2020 The approval was based on results from a late-stage trial in which Lynparza nearly doubled the lifespan of patients AstraZeneca…
FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer EH News Bureau Jun 30, 2020 The study demonstrated a statistically significant improvement in progression-free survival (PFS) as assessed by a blinded…
‘Ramadan, Diabetes & Me’ app tracks blood glucose levels and easily reports to healthcare… Usha Sharma Jun 19, 2015 MSD Pharmaceuticals (MSD India), a wholly-owned subsidiary of Merck & Co, Whitehouse Station, New Jersey, USA, has launched a…
